Markets
Stocks
Mutual Funds & ETF's
Sectors
Tools
Overview
Market News
Market Videos
Currencies
International
Treasury & Bonds
Search InvestCenter
Recent Quotes
My Watchlist
Indicators
Bayer Aktiengesellschaft American Depositary Shares (OP: BAYRY)
112.75 USD  +1.35 (+1.21%)
Official Closing Price  /  Updated: 8:10 PM EDT, Jun 18, 2013  /  Add to My Watchlist      
View: Quote News Research
All news about Bayer Aktiengesellschaft American Depositary Shares
 
< Previous 1 2
...
6 7 8 9 10 11 12 13 Next >
(MITI) Micromet’s Quarterly Report Shows Loss Increase
May 06, 2010
Micromet’s (MITI) first quarter fiscal 2010 loss per share came in at 23 cents, greater than the year-ago quarter’s loss of a penny. However, after adjusting for the change in fair value of warrants,... Read More
category MITI , Biotechnology , Healthcare , and 1 more.
from Stock Blog Hub
Loss Increases For Micromet
May 06, 2010
Micromet’s (NASDAQ:MITI) first quarter fiscal 2010 loss per share came in at 23 cents, greater than the year-ago quarter’s loss of a penny. However, after adjusting for the change in fair value of... Read More
category UK , MITI , Eurozone , and 5 more.
from DailyMarkets.com
Onyx Misses, Slips To Loss
May 05, 2010
Onyx Pharmaceuticals (NASDAQ:ONXX) reported a first quarter fiscal 2010 loss of 19 cents per share, worse than a profit of 7 cents reported in the year-ago period. However, after adjusting for... Read More
category External Research , Contributor , BAYRY , and 6 more.
from DailyMarkets.com
Bayer: Strong Quarter, Raises Outlook
May 05, 2010
Bayer’s (BAYRY) core earnings per share (EPS) during the first quarter of fiscal 2010 came in at €1.20 (approx $1.64) compared to €0.91 (approx. $1.26) in the year-ago period. The company recorded a... Read More
category Eurozone , Stocks , External Research , and 3 more.
from DailyMarkets.com
Updates, advisories and surprises
April 29, 2010
A roundup of the latest corporate earnings reports and what companies are saying about future quarters. Read More
category Earnings , NL:NL:MT , SI , and 11 more.
from MarketWatch
Acura tanks; Bayer, Onyx gain on rival's study
April 23, 2010
Acura Pharmaceuticals is the sharpest decliner among the small-cap drug stocks in early activity, with shares plunging on a negative FDA decision on its new painkiller Acurox. Read More
category APPY , Biotechnology , BAYRY , and 8 more.
from MarketWatch
Buy, Sell or Hold: Is Pfizer Inc. (NYSE: PFE) the Right Prescription for Your Portfolio?
April 19, 2010
In 2008, the journal Health Affairs reported that 25% of China's adult population  - about 375 million people - was "overweight" or "obese." That number is expected to double by 2028, and obesity is... Read More
category Buy Sell Hold
from Money Morning
3 Stocks The Analysts Love (CLX, ONXX, SPY, PPH, SBUX)
April 09, 2010
When Wall Street raises the grade, look for the momentum-investing crowd to rush in. Read More
from Investopedia Advisor Commentary
Bear Of The Day: Bayer AG
March 16, 2010
Bayer AG (BAYRY) reported fourth quarter core earnings per share of 0.90 surpassing 0.71 reported in the year-ago period. Bayer has been shifting its focus towards its HealthCare segment over the past... Read More
category Stocks , External Research , Contributor , and 2 more.
from DailyMarkets.com
(MITI) Micromet’s Fourth Quarter Loss Greater Than Expectations
March 05, 2010
Micromet’s (MITI) fourth quarter loss per share came in at 34 cents, wider than the Zacks Consensus Estimate of 18 cents and a loss of 12 cents reported in the prior-year period. For 2009, the company... Read More
category MITI , Biotechnology , ALL , and 5 more.
from Stock Blog Hub
Micromet Misses Expectations
March 05, 2010
Micromet’s (NASDAQ:MITI) fourth quarter loss per share came in at 34 cents, wider than the Zacks Consensus Estimate of 18 cents and a loss of 12 cents reported in the prior-year period. For 2009, the... Read More
category MITI , SNY , Stocks , and 4 more.
from DailyMarkets.com
Bayer Reports Lower Revenue
March 03, 2010
Revenues of Bayer (BAYRY) during the fourth quarter declined marginally by 0.6% to €7.87 billion from €7.92 billion in the corresponding period last year. For 2009, revenues came in at €31.16 billion,... Read More
category Featured
from Stock Blog Hub
Monday's biggest gaining and declining stocks
March 01, 2010
Stocks expected to move significantly in Monday's trading include Actelion, AIG, Dish, HSBC OSI, PepsiCo and RiskMetrics. Read More
category RISK , DDS , TOT , and 27 more.
from MarketWatch
Existing Home Sales Sank in January 2010
February 27, 2010
from Wall Street Greek
(ONXX) Onyx Pharmaceuticals Reports Higher Revenues
February 24, 2010
Onyx Pharmaceuticals (ONXX) has reported a fourth quarter loss of 9 cents per share, much better than a loss of 53 cents reported in the year-ago period. However, after adjusting non recurring items... Read More
category ONXX , Onyx Pharmaceuticals Inc , Biotechnology , and 1 more.
from Stock Blog Hub
Label Expansion For BIIB’s Rituxan
February 22, 2010
Recently, Biogen Idec (NASDAQ:BIIB) and Genentech, Inc., a wholly-owned member of the Roche Group, received approval from the US Food and Drug Administration (FDA) for the use of Rituxan (rituximab)... Read More
category External Research , Contributor , CEPH , and 6 more.
from DailyMarkets.com
Drug stocks drop with broader market
January 21, 2010
Industry slides as the broader market flinches at news that the Obama administration plans to push for tighter restrictions on U.S. banks. Read More
category ELN , Biotechnology , BAX , and 12 more.
from MarketWatch
Morgan Stanley Upgrades AstraZeneca, Downgrades Sanofi, Bayer (AZN, SNY, BAYRY)
January 20, 2010
Visit StreetInsider.com at http://www.streetinsider.com/news.php?st=p&id=5260837 for the full story. Read More
from StreetInsider.com News Articles
Novo Nordisk, Bayer and J&J lead downward trend
January 15, 2010
As drug and biotech benchmarks retreat, shares of Novo Nordisk Bayer and Johnson & Johnson are among those leading the sector lower. Read More
category Biotechnology , JNJ , Analyst , and 12 more.
from MarketWatch
FDA Warns Bayer, Eli Lilly, Cephalon and Amylin Pharmaceuticals about Faulty Ads- lesson for Drug Companies
January 15, 2010
FDA sent warning letters to four drug companies, saying their promotional materials for four drugs make inaccurate or incomplete statements. The U.S. Food and Drug Administration mentioned that Bayer... Read More
category Tech and Web , AMLN , Bayer , and 8 more.
from CEOWORLD Magazine
(ENDP) Endo Pharmaceuticals Hits FDA Roadblock With Aveed
December 11, 2009
Endo Pharmaceuticals (ENDP) hit a roadblock related to the approval of Aveed. Recently, the company received a complete response letter (CRL) from the US Food and Drug Administration (FDA) regarding... Read More
category ENDP , AUXL , Healthcare , and 3 more.
from Stock Blog Hub
(PFE) Bayer Advances on Alzheimer’s Plan
December 04, 2009
Alzheimer’s disease (AD) is a devastating neuro-degenerative disease that affects people over the age of 60. The onset of the disease is often so gradual and the early signs are so mild that they are... Read More
category NVS , Pfizer Inc/ , Shire Limited , and 5 more.
from Stock Blog Hub
Dubai jitters rattle drug stocks; QLT gains
November 27, 2009
The drug sector lost ground in lockstep with the broader stock market in post-Thanksgiving trading, with investors showing concern about an impending credit crisis in Dubai. Read More
category AZN , RHHBY , Biotechnology , and 11 more.
from MarketWatch
Europe drug stocks rally; Cephalon slides
November 23, 2009
BOSTON (MarketWatch) -- Drug stocks advanced in early action Monday, boosted by a rally among major European drugmakers, while shares of Cephalon Inc. fell on news that a later-stage clinical study for... Read More
category RHHBY , Market News , Biotechnology , and 12 more.
from MarketWatch
Trading Outlook for BioElectronics Corporation Issued by StockPreacher.com
November 12, 2009
from GlobeNewswire News Releases
India's killer pesticide: world wants endosulfan ban, but India holds out
October 20, 2009
DailyFinance : The state of Kerala in India is held up in global circles as a paragon of progressiveness. The southern region has a 97 percent literacy rate, the highest in India and far higher than... Read More
category poison , pesticides , toxic , and 11 more.
from DailyFinance.com
Israel stocks steady; Koor wants more Makhteshim
October 13, 2009
Israeli stocks were steady to lower on Tuesday, as traders bought Makhteshim-Agan, Discount Bank and real-estate companies while selling off Israel Chemicals and two other major banks. Read More
category UMZRF , PTNR , Computer Software , and 30 more.
from MarketWatch
Monday's biggest gaining and declining stocks
October 05, 2009
Among the companies whose shares are expected to see active trading in Monday’s session are the major U.S. banks as well as Barclays, Fortune Industries, Ivanhoe Mines, Philip Morris, Steris, Syngenta,... Read More
category HK:5 , kdcxf , BCS , and 47 more.
from MarketWatch
Israel stocks up: Deutsche reviews the banks
October 05, 2009
Israeli stocks rise, led by strength in phone-service provider Bezeq as well as financial and real estate stocks. Read More
category UMZRF , MON , PTNR , and 29 more.
from MarketWatch
Wednesday's biggest gaining and declining stocks
September 30, 2009
Among the companies whose shares are expected to see active trade in Wednesday’s session are Boston Scientific, CIT, Darden Restaurants, Granite Construction, Jabil Circuit, J&J, Micron Technology,... Read More
category NKE , KFT , BAYRY , and 33 more.
from MarketWatch
< Previous 1 2
...
6 7 8 9 10 11 12 13 Next >
Stock Market XML and JSON Data API provided by FinancialContent Services, Inc.
Nasdaq quotes delayed at least 15 minutes, all others at least 20 minutes.
Markets are closed on certain holidays. Stock Market Holiday List
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Press Release Service provided by PRConnect.
Stock quotes supplied by Telekurs USA
Postage Rates Bots go here